SCHEMBL5774041

SCHEMBL5774041

CC(C)c1nc(Cl)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.51
ADORA2A P29274 4/20 0.51
ADORA1 P30542 4/20 0.51
ADORA2B P29275 3/20 0.51
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 5/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41
GSK3B P49841 1/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
CDC7 O00311 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773858 0.83 ADORA1 (0.51) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL5774543 0.81 ADORA1 (0.48) ADORA3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL5776767 0.80 KDM4E (0.47) ADORA2AADORA1KDM4EALDH1A1HPGD
SCHEMBL5771482 0.80 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5776325 0.80 ADORA1 (0.54) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL5773135 0.77 SMN1; SMN2 (0.55) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL5773970 0.75 ADORA1 (0.49) ADORA3ADORA2AADORA1ADORA2BKDM4E
SCHEMBL5773513 0.75 ADORA3 (0.53) ADORA3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL5772105 0.74 KDM4E (0.44) ADORA3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL14063546 0.71 GSK3B (0.74) ADORA3ADORA2AADORA1ADORA2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed